Related Experiment Video
Updated: Jun 20, 2026
07:51
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
Multiple testing for bioequivalence with pharmacokinetic data in 2 x 2 crossover designs
1Institute of Statistics, National Central University, Jhongli, Taiwan. ychen@stat.ncu.edu.tw
Statistics in Medicine
|September 18, 2009
Summary
This study introduces a new statistical test for global bioequivalence in pharmacokinetic studies. The proposed method offers greater power and reliability in comparing drug concentration-time curves than traditional tests.
Area of Science:
- Pharmacokinetics
- Biostatistics
- Drug Development
Background:
- Evaluating drug equivalence is crucial in pharmaceutical development.
- Pharmacokinetic (PK) studies assess drug absorption, distribution, metabolism, and excretion.
- Traditional bioequivalence tests may lack power in certain scenarios.
Purpose of the Study:
- To develop and evaluate a novel statistical method for assessing global bioequivalence.
- To compare the proposed method against conventional univariate and bivariate tests.
- To analyze drug concentration-time curves directly for equivalence.
Main Methods:
- Utilized a generalized gamma distribution for drug concentrations.
- Employed a one-compartment PK model for mean concentrations over time.
- Proposed a multiple test based on the supreme distance between concentration-time curves.
Main Results:
- The proposed test demonstrated higher power in detecting global bioequivalence.
- The new method maintained its statistical level effectively when bioequivalence was violated.
- Monte Carlo simulations indicated superiority over conventional tests.
Conclusions:
- The novel supreme distance test provides a more powerful and reliable approach for global bioequivalence assessment.
- This method enhances the evaluation of drug concentration-time profiles in PK studies.
- The findings support improved drug product comparison and regulatory decision-making.
Related Concept Videos
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:16Bioequivalence Data: Statistical Interpretation
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...